Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (19767)	6/7/1998 2:15:00 AM
From: Sonny McWilliams	Respond to of 27012

Sonki. WLA. This news on WLA was not such a big deal. NIH had been studying to see if Rezulin could be used on people who may get Diabetes because they have an impaired glucose tolerance. They decided to stop this research because someone died of Liver failure. I don't think it has been proven that it came from this drug. Anyhow, Rezulin is still used effectively for people who have Diabetes 2. Much to do over nothing. Remember, lots of studies get discontinued. I don't think Friday before the 4th of July is a Holiday. Sonny